MedPath

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies

Phase 3
Completed
Conditions
HIV Infections
Pneumonia, Pneumocystis Carinii
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Registration Number
NCT00000714
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Bellevue Hosp / New York Univ Med Ctr, New York, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Montefiore Med Ctr / Bronx Municipal Hosp, Bronx, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

City Hosp Ctr at Elmhurst / Mount Sinai Hosp, Elmhurst, New York, United States

and more 18 locations

The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate Symptoms

Phase 2
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
224
Registration Number
NCT00000990
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Milton S Hershey Med Ctr, Hershey, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

City Hosp Ctr at Elmhurst / Mount Sinai Hosp, Elmhurst, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Bellevue Hosp / New York Univ Med Ctr, New York, New York, United States

and more 29 locations

A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush

Phase 4
Completed
Conditions
Candidiasis, Oral
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
948
Registration Number
NCT00000951
Locations
๐Ÿ‡บ๐Ÿ‡ธ

State of MD Div of Corrections / Johns Hopkins Univ Hosp, Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

Boston Med Ctr, Boston, Massachusetts, United States

๐Ÿ‡บ๐Ÿ‡ธ

MetroHealth Med Ctr, Cleveland, Ohio, United States

and more 51 locations

Prevention of Kidney Transplant Rejection

Phase 3
Completed
Conditions
End-Stage Renal Disease
Chronic Allograft Nephropathy
First Posted Date
2001-08-31
Last Posted Date
2013-01-25
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Registration Number
NCT00005010
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Ilene Blechman-Krom, Rockville, Maryland, United States

The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS

Not Applicable
Completed
Conditions
HIV Infections
Cytomegalovirus Retinitis
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
50
Registration Number
NCT00000989
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UCLA CARE Center CRS, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Beth Israel Deaconess - East Campus A0102 CRS, Boston, Massachusetts, United States

๐Ÿ‡บ๐Ÿ‡ธ

Memorial Sloan-Kettering Cancer Ctr., New York, New York, United States

and more 1 locations

A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
60
Registration Number
NCT00000952
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Harlem Hosp. Ctr. NY NICHD CRS, New York, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

The Children's Hosp. of Philadelphia IMPAACT CRS, Philadelphia, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

HMS - Children's Hosp. Boston, Div. of Infectious Diseases, Boston, Massachusetts, United States

and more 9 locations

A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.

Phase 1
Withdrawn
Conditions
Encephalopathy
Radiculitis
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Registration Number
NCT00000856

Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies

Phase 1
Completed
Conditions
HIV Infections
Pregnancy
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
14
Registration Number
NCT00000888
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Children's Hospital of Michigan NICHD CRS, Detroit, Michigan, United States

๐Ÿ‡บ๐Ÿ‡ธ

Univ. of Miami Miller School of Medicine - Jackson Memorial Hosp., Miami, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Univ. of Miami Ped. Perinatal HIV/AIDS CRS, Miami, Florida, United States

and more 2 locations

An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens

Phase 3
Completed
Conditions
End-Stage Renal Disease
Kidney Transplantation
Interventions
Biological: Intravenous immune globulin (IVIG)
First Posted Date
2001-08-31
Last Posted Date
2017-01-11
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
100
Registration Number
NCT00000935
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Ann Limberger, Rockville, Maryland, United States

A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease

Not Applicable
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2016-10-31
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Registration Number
NCT00000662
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Glaxo Wellcome Inc, Research Triangle Park, North Carolina, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath